Texas has an active Medical Board with specific rules for medical advertising, and the DTPA gives consumers and the state AG independent enforcement authority over deceptive healthcare marketing.
State-level overview
Texas healthcare marketing is shaped by the Texas Medical Board (TMB), the Texas Deceptive Trade Practices Act (DTPA), and the Texas AG's consumer protection authority. The TMB has specific advertising rules in 22 TAC §164 that cover physician-advertising conduct, specialty claim requirements, and supervision disclosures. The DTPA is unusual in permitting private plaintiffs to bring claims in addition to AG actions - creating multiple enforcement vectors for the same marketing conduct.
The TMB's advertising rules under 22 TAC §164 cover deceptive advertising, specialty claim language, and supervision representation. Texas has specific rules on 'board-certified' language, on how cosmetic and aesthetic specialties can be claimed by physicians, and on the supervision requirements for nurse injectors and non-physician providers in aesthetic practices. Texas has been particularly active on telehealth prescribing rules as the state has grown as a telehealth hub.
The Texas AG uses DTPA authority against healthcare marketing that deceives consumers. Recent enforcement has targeted weight-loss clinic advertising, compounded medication marketing, and telehealth prescribing practices. DTPA's treble-damages provision for knowing violations creates significant exposure for practices with documented-knowledge-of-deception fact patterns.
Enforcement focus
Texas has specific rules on the supervision relationship between physicians and nurses performing medical aesthetic services. Marketing that implies independent injector practice has been TMB-disciplined.
Texas is one of the largest telehealth GLP-1 markets. The Texas AG has been active on marketing that minimizes clinical evaluation or misrepresents the availability of specific medications.
Texas has specific rules on compounding pharmacy advertising, and the AG has pursued cases on cross-state marketing by compounding-pharmacy-affiliated clinics.
Unlike most state consumer-protection laws, the DTPA permits private plaintiffs to sue - including class actions. Healthcare marketing that deceives consumers creates exposure to private lawsuits in addition to AG or Medical Board action.
Patterns we flag in Texas
'Board-certified' without specific board disclosure
Why: 22 TAC §164 requires specific certifying-board disclosure when 'board-certified' language is used.
'Our expert injectors' / 'book with your injector' without supervision language
Why: TMB treats implied independence as a disciplinary-level supervision misrepresentation.
Compounded GLP-1 marketed as equivalent to Ozempic/Wegovy
Why: Texas AG has specifically pursued this pattern under DTPA.
Guarantee language on weight-loss outcomes
Why: DTPA class-action exposure in addition to AG action.
Telehealth marketing that omits evaluation requirements
Why: TMB has begun enforcement on marketing that undersells the clinical evaluation step.
By specialty
By specialty in Texas
Specialty rules stack on top of state rules. Find the specialty-specific framework that applies to your practice.
Disclaimer
This summary reflects general patterns in Texas healthcare marketing enforcement; it is not legal advice. For state-specific guidance on your practice, consult a Texas-licensed healthcare marketing attorney.
RegenCompliance applies federal FDA and FTC rules plus the most-enforced state patterns automatically. Texas-specific language is part of the rule set.
Other state guides
See allCalifornia healthcare marketing sits under the strictest state-level enforcement environment in the country - Medical Board of California rules, Business & Professions Code §17500 false advertising authority, and active AG consumer protection.
Read state guideFlorida's regulatory environment is defined by the Board of Medicine, FDUTPA, and an AG office that has been active on healthcare marketing - particularly in the fast-growing med spa, weight-loss, and regen categories.
Read state guideNew York's healthcare marketing environment is defined by OPMC, an aggressive AG office, and the state's particularly strict corporate-practice-of-medicine rules - each of which shapes how practices can advertise.
Read state guide